in Newswire April 22, 2019

Class Action Over Quincy Bioscience’s Prevagen Brain Health Claims Transferred to New York

by Corrado Rizzi

Last Updated on April 22, 2019

Spath v. Quincy Bioscience Holding Company, Inc. et al.

Filed: April 22, 2019 § 1:19-cv-03521

A class action filed in August 2018 claims Quincy Bioscience falsely misrepresented the apparent brain heath benefits of Prevagen.

Last Updated on April 22, 2019 — 4:04 PM

Corrado Rizzi

Corrado Rizzi is the News Editor and a writer for

About is a group of online professionals (designers, developers and writers) with years of experience in the legal industry.

Learn More

Before commenting, please review our comment policy.